Coexisting driver alterations in non-small cell lung cancer: Prevalence, clonal architecture, and impact on survival and progression
European Journal of Cancer · 2026
DOI: 10.1016/j.ejca.2026.116936 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Rashmi Shah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, QEII Health Sciences Centre and Dalhousie University, Halifax, NS, Canada. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Mutation, Proto-Oncogene Proteins p21(ras). Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Roche Canada, AstraZeneca Canada Inc.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, QEII Health Sciences Centre and Dalhousie University, Halifax, NS, Canada.
- Department of Pathology, QEII Health Sciences Centre and Dalhousie University, Halifax, NS, Canada. Electronic address: zhaolin.xu@nshealth.ca.
Förderung
- Roche Canada
- AstraZeneca Canada Inc
Zitieren
APA
Shah, R., Pathak, G. P., Fris, J., Castonguay, M., Gillan, T., Carter, M. D., & Xu, Z. (2026). Coexisting driver alterations in non-small cell lung cancer: Prevalence, clonal architecture, and impact on survival and progression. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.116936
Vancouver
Shah R, Pathak GP, Fris J, Castonguay M, Gillan T, Carter MD, et al. Coexisting driver alterations in non-small cell lung cancer: Prevalence, clonal architecture, and impact on survival and progression. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2026.116936
BibTeX
@article{Shah2026,
author = {Shah, Rashmi and Pathak, Gopal P and Fris, John and Castonguay, Mathieu and Gillan, Tanya and Carter, Michael D and Xu, Zhaolin},
title = {Coexisting driver alterations in non-small cell lung cancer: Prevalence, clonal architecture, and impact on survival and progression},
journal = {European Journal of Cancer},
year = {2026},
doi = {10.1016/j.ejca.2026.116936}
}
EUVIMED